InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-10.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Scanlan Sean F., Vice-Président Senior. Insider active across 1 company, notably Treace Medical Concepts, INC.. In total, 27 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €12k. Activity tracked since 10 November 2021. The latest transaction was filed on 8 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations27 total
401 shares0Common StockSEC:0001193125-26-102763:0
16,875 shares@ US$1.056.5% of flowCommon StockSEC:0001193125-26-047313:0
53,500 shares@ US$0.7214.3% of flowCommon StockSEC:0001193125-26-021450:0
208 shares0Common StockSEC:0001193125-25-253801:0
9,814 shares0Common StockSEC:0000950170-25-107555:0
33,437 shares@ US$0.717811.3% of flowCommon StockSEC:0000950170-25-097601:0
50,000 shares@ US$1.0521.2% of flowCommon StockSEC:0000950170-25-042291:0
401 shares0Common StockSEC:0000950170-25-037572:0
140,625 shares0Common StockSEC:0000950170-25-008973:0
4,821 shares0Common StockSEC:0000950170-25-005580:0
33,750 shares@ US$0.09721.3% of flowCommon StockSEC:0000950170-24-106856:0
120,900 shares0Common StockSEC:0000950170-24-095009:0
389 shares0Common StockSEC:0000950170-24-030429:0
65,025 shares0Common StockSEC:0001209191-24-001589:0
211 shares0Common StockSEC:0001209191-23-054433:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-030857:0
505 shares@ US$24.415.1% of flowCommon StockSEC:0001209191-23-018042:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-010955:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-003385:0
25,000 shares@ US$0.101.1% of flowCommon StockSEC:0001209191-22-057418:0
3,400 shares0Common StockSEC:0001209191-22-054666:0
6,575 shares0Common StockSEC:0001567619-22-006733:0
25,000 shares@ US$1.050.014% mcap15.2% of flowCommon StockSEC:0001567619-22-006400:0
21,127 shares@ US$1.050.011% mcap12.5% of flowCommon StockSEC:0001567619-22-003261:0
8,231 shares@ US$1.570.0066% mcap7.3% of flowCommon StockSEC:0001567619-22-001142:0
25 of 27 declarations
About Scanlan Sean F.
Sean F. Scanlan is the SVP of Marketing at TREACE MEDICAL CONCEPTS, INC. He is responsible for the company's marketing and communication strategies, contributing to its visibility and growth in the medical market.
